Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest Health Care Reform Draft Details Government Responsibilities

This article was originally published in PharmAsia News

Executive Summary

The new draft of China's health care reform plan was released on Oct. 14 to solicit public opinion for the second time. It systematically addresses the reform's direction, objectives, principles and major measures. Zhu Chang-Hao, vice-chairman of the China Association of Pharmaceutical Commerce, sees the biggest highlight as the government's clear definition of responsibilities for the first time, realistically sharing the investment load between the central and local governments at all levels. However, some parts are not clearly spelled out: for instance, the plan does not indicate how to dissociate profits between health care services and medicines, or how to balance the interests among national taxes, health care institutions, physicians, pharmaceutical companies and patients. Analysts note the reform will help to strengthen domestic growth and economic stability. (Click here for more - Chinese Language)

You may also be interested in...

China Set To Launch Sweeping Health System Reforms, Aimed In Part At Reversing Stratified Access To Medicine, Hospitals, Insurance

BEIJING - China's central government is set to launch sweeping reforms of the country's health system, with the ultimate goal of providing universal health care by the year 2020

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 

Hair Supplement Linked To Cases Of Severe Hepatitis In France

France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts